Purchase Order 75N92022P00181
Award Date
9/11/22
Potential Completion Date
9/11/23
Potential Value
$133K
Federal Agency
National Heart Lung and Blood Institute
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $100,883.32 firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of genomic analysis instruments and reagents. The 1-year service and support contract is for Illumina brand equipment, with no set-aside used. Illumina has previously provided sequencing systems, reagents, and bioinformatics products to support genomic research and...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $13,401.96 firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of genetic sequencing systems and related products. The order is for the repair of one of the agency's Illumina DNA sequencing machines located in Bethesda, Maryland. Illumina has a history of providing sequencing instruments, reagents, and support services to various federal agencies,...
This firm fixed-price delivery order was awarded by the National Heart Lung and Blood Institute (NHLBI), which is part of the National Institutes of Health (NIH), a civilian agency. The contract, valued at $110,254.47, is with Illumina, Inc., a manufacturer of genomic sequencing systems and consumables. Illumina has provided these products and associated services to support genomic research and analysis across various federal agencies in the past. This order does not include any set-aside...
This firm fixed-price delivery order was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Heart Lung and Blood Institute to Illumina, Inc. for the provision of genomic sequencing systems, reagents, and related support services. The $139,090.77 award does not have a set-aside designation. Illumina is a manufacturer of genetic and genomic analysis instruments and solutions, and has previously supported federal research and diagnostics...
This is a firm fixed-price purchase order awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The $383,592.54 contract is for the provision of various Illumina sequencing systems, reagents, consumables, and related services to support genomic sequencing and analysis. The award is not set aside and was made on a sole-source basis, with Illumina identified as the sole manufacturer of the required sequencing...
This federal contract award from the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), is a firm fixed price delivery order issued to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions. The $26,672.00 award is for the provision of Illumina's proprietary sequencing instruments, reagents, and related consumables and services, including NextSeq, NovaSeq, MiSeq, and iSeq platforms, to support genomic research and...
The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a firm fixed price purchase order to Illumina, Inc. for a SILVER SUPPORT PLAN ON NOVASEQ6000 S/N A00428 with a potential value of $22,646.33 and a completion date of February 4, 2024. This short-term contract does not have a set-aside designation. Illumina, a for-profit manufacturer of genetic sequencing and analysis instruments and reagents, has a history of providing...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents, for MISSEQ, CBOT2 AND HISEQ 4000 BRONZE AND SILVER MAINTENANCE PLANS. The $124,639.96 contract does not have a set-aside designation. Illumina has previously been awarded federal contracts by agencies such as the NIH, CDC, USDA, and VA...
This is a federal contract award made by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), to Illumina, Inc. The $221,607.32 firm fixed price delivery order is for the provision of reagents to support genomic sequencing and analysis. The award has no set-aside designation. Illumina, a manufacturer of sequencing instruments and related consumables, has previously received both prime and subcontract awards from various...
This is a firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract has a ceiling value of $646,396.36 and no set-aside designation. Illumina, a manufacturer of sequencing and array-based genomic analysis solutions, will provide a range of sequencing systems, reagents, and services to support NHLBI's research and diagnostics needs. Illumina has a history of...